Publication Date
8-25-2022
Journal
Metabolites
DOI
10.3390/metabo12090787
PMID
36144194
PMCID
PMC9505353
PubMedCentral® Posted Date
8-25-2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
insulin homeostasis, ABO blood type, metabolites, gut microbiome, mediation analysis
Abstract
Non-O blood groups are associated with decreased insulin sensitivity and risk of type 2 diabetes. A recent study pinpointed the associations between ABO blood groups and gut microbiome, which may serve as potential mediators for the observed increased disease risks. We aimed to characterize associations between ABO haplotypes and insulin-related traits as well as potential mediating pathways. We assessed insulin homeostasis in African Americans (AAs; n = 109) and non-Hispanic whites (n = 210) from the Microbiome and Insulin Longitudinal Evaluation Study. The ABO haplotype was determined by six SNPs located in the ABO gene. Based on prior knowledge, we included 21 gut bacteria and 13 plasma metabolites for mediation analysis. In the white study cohort (60 ± 9 years, 42% male), compared to the O1 haplotype, A1 was associated with a higher Matsuda insulin sensitivity index, while a lower relative abundance of Bacteroides massiliensis and lactate levels. Lactate was a likely mediator of this association but not Bacteroides massiliensis. In the AAs group (57 ± 8 years, 33% male), we found no association between any haplotype and insulin-related traits. In conclusion, the A1 haplotype may promote healthy insulin sensitivity in non-Hispanic whites and lactate likely play a role in this process but not selected gut bacteria.
Included in
Endocrinology, Diabetes, and Metabolism Commons, Medical Microbiology Commons, Virology Commons
Comments
Associated Data